AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8757210 — intervention group
Group type: COMPARATOR
Intervention: High-allergen gloves
Number of subjects: 52
Study 8757210 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgery days
Number of subjects: 52
Study 1358235 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine q.d.s.
Number of subjects: 9
Study 1358235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 6443576 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy
Number of subjects: 29
Study 6443576 — intervention group
Group type: COMPARATOR
Intervention: Chronic administration of an LHRH agonistic analogue by parenteral and/or intranasal routes
Number of subjects: 29
Study 30341003 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oxytocin (6.6 mU/minute)
Number of subjects: 1351
Study 30341003 — intervention group
Group type: COMPARATOR
Intervention: Low-dose oxytocin (3.3 mU/minute)
Number of subjects: 1351
Study 29408705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HyperBOT) at 2.5 ATA for 60 minutes
Number of subjects: 79
Study 29408705 — intervention group
Group type: COMPARATOR
Intervention: Normobaric oxygen therapy (NormBOT) at 1.5 ATA
Number of subjects: 79
Study 26597468 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block (deep plus superficial)
Number of subjects: 48
Study 26597468 — intervention group
Group type: COMPARATOR
Intervention: Intermediate cervical plexus block
Number of subjects: 48
Study 26597468 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block
Number of subjects: 48
Study 24593826 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBNP in high BNP group (n = 28)
Number of subjects: 105
Study 24593826 — intervention group
Group type: COMPARATOR
Intervention: dobutamine in high BNP group (n = 30)
Number of subjects: 105
Study 24593826 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBNP in extra-high BNP group (n = 24)
Number of subjects: 105
Study 24593826 — intervention group
Group type: COMPARATOR
Intervention: dobutamine in extra-high BNP group (n = 23)
Number of subjects: 105
Study 22891214 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery with hyperglycemia after hypoglycemia
Number of subjects: 0
Study 22891214 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery with normoglycemia after hypoglycemia
Number of subjects: 0
Study 22891214 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery with hyperglycemia after hypoglycemia with vitamin C infusion
Number of subjects: 0
Study 21152391 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased activity in the fusiform gyrus (FG) correlated with trait anxiety and negatively correlated with WM performance.
Number of subjects: 0
Study 21152391 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased activity in the right lateral prefrontal cortex (PFC) negatively correlated with trait anxiety.
Number of subjects: 0
Study 21152391 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement of medial and left lateral PFC in coping with distraction.
Number of subjects: 0
Study 17632038 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure in vivo aimed to systematically reduce the perceived harmfulness of activities
Number of subjects: 0
Study 17632038 — intervention group
Group type: COMPARATOR
Intervention: Graded activity that did not address assumptions about harmfulness
Number of subjects: 0
Study 16376646 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct plating onto standard media
Number of subjects: 100
Study 16376646 — intervention group
Group type: COMPARATOR
Intervention: Amies transport medium after 4 hours
Number of subjects: 100
Study 16376646 — intervention group
Group type: COMPARATOR
Intervention: Amies transport medium after 24 hours
Number of subjects: 100
Study 16376646 — intervention group
Group type: COMPARATOR
Intervention: Amies transport medium for cases that did not yield organisms by direct plating
Number of subjects: 100
Study 16376646 — intervention group
Group type: COMPARATOR
Intervention: Comparison of recovery rates
Number of subjects: 100
Study 11172843 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) plus tibolone (2.5 mg/d orally)
Number of subjects: 30
Study 11172843 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) plus tibolone
Number of subjects: 30
Study 11172843 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist (GnRH‐a) plus placebo (1 tablet per day orally)
Number of subjects: 30
Study 9625399 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral alcohol reduction intervention program
Number of subjects: 641
Study 9625399 — intervention group
Group type: COMPARATOR
Intervention: Control observation group
Number of subjects: 641
Study 8169458 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous 200-ng bolus of octreotide
Number of subjects: 9
Study 8169458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3277484 — intervention group
Group type: EXPERIMENTAL
Intervention: Oximeter data available to anesthesia team
Number of subjects: 152
Study 3277484 — intervention group
Group type: COMPARATOR
Intervention: Oximeter data unavailable to anesthesia team
Number of subjects: 152
Study 3277484 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA Physical Status 3 and 4 patients
Number of subjects: 152
Study 31566888 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual task (Kinect, no physical contact)
Number of subjects: 50
Study 31566888 — intervention group
Group type: EXPERIMENTAL
Intervention: Real task (Keyboard, with physical contact)
Number of subjects: 50
Study 31566888 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual training
Number of subjects: 50
Study 31566888 — intervention group
Group type: COMPARATOR
Intervention: Non-touch task (virtual environment)
Number of subjects: 50
Study 28536184 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g casein protein with 2 g free leucine (PRO+leu)
Number of subjects: 36
Study 28536184 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g casein protein without 2 g free leucine (PRO)
Number of subjects: 36
Study 28536184 — intervention group
Group type: COMPARATOR
Intervention: Noncaloric placebo (PLA)
Number of subjects: 36
Study 28536184 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein ingestion before sleep
Number of subjects: 36
Study 27837162 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop (CL) on day 1 of sensor insertion
Number of subjects: 12
Study 27837162 — intervention group
Group type: COMPARATOR
Intervention: Closed-loop (CL) on day 3-4 after sensor insertion
Number of subjects: 12
Study 26590903 — intervention group
Group type: EXPERIMENTAL
Intervention: Home enteral nutrition through a jejunostomy for six weeks
Number of subjects: 54
Study 26590903 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 54
Study 24285757 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan (with preoperative dose)
Number of subjects: 50
Study 24285757 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan (without preoperative dose)
Number of subjects: 50
Study 24285757 — intervention group
Group type: COMPARATOR
Intervention: Control (no alvimopan)
Number of subjects: 50
Study 21263080 — intervention group
Group type: EXPERIMENTAL
Intervention: WL + PA
Number of subjects: 0
Study 21263080 — intervention group
Group type: COMPARATOR
Intervention: PA
Number of subjects: 0
Study 21263080 — intervention group
Group type: COMPARATOR
Intervention: SA
Number of subjects: 0
Study 18932221 — intervention group
Group type: EXPERIMENTAL
Intervention: Sapropterin dihydrochloride (5, 10, or 20 mg/kg/day)
Number of subjects: 80
Study 17147074 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ultrasound (US)
Number of subjects: 58
Study 17147074 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham-US)
Number of subjects: 58
Study 12669757 — intervention group
Group type: EXPERIMENTAL
Intervention: Preview benefit with occluded old items
Number of subjects: 0
Study 12669757 — intervention group
Group type: COMPARATOR
Intervention: Preview benefit with non-occluded old items
Number of subjects: 0
Study 12669757 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement of irrelevant stimuli
Number of subjects: 0
Study 10235195 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg nocte
Number of subjects: 35
Study 10235195 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 35
Study 8907720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (NEF) 200 mg under fasting conditions
Number of subjects: 24
Study 8907720 — intervention group
Group type: COMPARATOR
Intervention: Nefazodone (NEF) 200 mg after a high‐fat breakfast
Number of subjects: 24
Study 1875712 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g ethanol/kg body weight
Number of subjects: 8
Study 1875712 — intervention group
Group type: COMPARATOR
Intervention: Iso-volumic control drink
Number of subjects: 8
Study 6198807 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 100
Study 6198807 — intervention group
Group type: COMPARATOR
Intervention: Anti-oxidants (tocopherol, glutathione, cysteamine, cysteine)
Number of subjects: 100
Study 31683350 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvastus approach (group S)
Number of subjects: 93
Study 31683350 — intervention group
Group type: COMPARATOR
Intervention: Parapatellar approach (control group P)
Number of subjects: 93
Study 29741913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparse representation‐based variable selection (SRVS)
Number of subjects: 0
Study 29741913 — intervention group
Group type: COMPARATOR
Intervention: ANOVA-based gene selection approaches
Number of subjects: 0
Study 27523782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking classes focusing on salt reduction
Number of subjects: 68
Study 27523782 — intervention group
Group type: COMPARATOR
Intervention: Lectures about a healthy lifestyle
Number of subjects: 68
Study 24603072 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mg/kg r‐tPA
Number of subjects: 3035
Study 24603072 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 3035
Study 21475963 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG IUS)
Number of subjects: 230
Study 21197501 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading of single implants placed in extraction sockets
Number of subjects: 139
Study 21197501 — intervention group
Group type: COMPARATOR
Intervention: Immediate loading of single implants placed in healed ridges
Number of subjects: 139
Study 21197501 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implants (both groups)
Number of subjects: 139
Study 18450623 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-midvastus approach (group A)
Number of subjects: 100
Study 18450623 — intervention group
Group type: COMPARATOR
Intervention: Standard approach (group B)
Number of subjects: 100
Study 15877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified support to quit smoking and dietary modification
Number of subjects: 172
Study 15877991 — intervention group
Group type: COMPARATOR
Intervention: General lifestyle advice (Control)
Number of subjects: 172
Study 15877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation (in intervention group)
Number of subjects: 172
Study 12706322 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 73
Study 12706322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 10627726 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite coated femoral prostheses
Number of subjects: 55
Study 10627726 — intervention group
Group type: COMPARATOR
Intervention: Nonhydroxyapatite coated femoral prostheses (Control)
Number of subjects: 55
Study 7782428 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU of HCG
Number of subjects: 8
Study 7782428 — intervention group
Group type: COMPARATOR
Intervention: Control values from the menstrual cycle prior to experiments
Number of subjects: 8
Study 1851620 — intervention group
Group type: EXPERIMENTAL
Intervention: External radiation to the breast (50 Gy)
Number of subjects: 216
Study 1851620 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 216
Study 6111525 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of atenolol (Tenormin) for 3 days
Number of subjects: 40
Study 6111525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6111525 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenetyllinhydrochloride, diazepam, oxazepam, and alcohol
Number of subjects: 40
Study 6499553 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chest percussion with postural drainage (CPT)
Number of subjects: 53
Study 6499553 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative respiratory care
Number of subjects: 53
Study 30447668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular cholecalciferol (vitamin D)
Number of subjects: 24
Study 30447668 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group of non-ECMO patients)
Number of subjects: 24
Study 30447668 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO patients
Number of subjects: 24
Study 30447668 — intervention group
Group type: COMPARATOR
Intervention: Non-ECMO patients
Number of subjects: 24
Study 26829509 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous tranexamic acid
Number of subjects: 332
Study 26829509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 24688085 — intervention group
Group type: EXPERIMENTAL
Intervention: beta‐hydroxy‐beta‐methylbutyrate/arginine/glutamine supplement (Group A)
Number of subjects: 40
Study 24688085 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 40
Study 22296842 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic toric IOL (Acrysof)
Number of subjects: 50
Study 22296842 — intervention group
Group type: COMPARATOR
Intervention: Silicone toric IOL (Staar)
Number of subjects: 50
Study 20350039 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program
Number of subjects: 667
Study 20350039 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 667
Study 18551818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2 g, single i.v. administration)
Number of subjects: 209
Study 18551818 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone (2 g, single i.v. administration)
Number of subjects: 209
Study 16502720 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged transthoracic microelectrostimulation
Number of subjects: 0
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 29
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 29
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 29
Study 11972726 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 29
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin-selective reuptake inhibitors (SSRIs)
Number of subjects: 29
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 29
Study 11972726 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic antidepressants
Number of subjects: 29
Study 11972726 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline and Fluoxetine
Number of subjects: 29
Study 10876473 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial education sessions (7 sessions, 20 minutes each, 2 days a week for 4.5 weeks)
Number of subjects: 10
Study 10876473 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study 8956464 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot needle with Y-shaped hub and side-port for guide wire insertion
Number of subjects: 60
Study 8956464 — intervention group
Group type: EXPERIMENTAL
Intervention: Central approach via the internal jugular vein
Number of subjects: 60
Study 8956464 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular approach via the junction of the internal jugular vein and subclavian vein
Number of subjects: 60
Study 8956464 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular approach via the subclavian vein
Number of subjects: 60
Study 1941428 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent hospital program designed to prepare children for emergency room visits
Number of subjects: 148
Study 1941428 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical examination in an emergency room (Phase 2)
Number of subjects: 148
Study 1941428 — intervention group
Group type: COMPARATOR
Intervention: Control group (children who did not attend the program)
Number of subjects: 148
Study 6283801 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunelax (fibre-containing bulk-purgative)
Number of subjects: 12
Study 31764009 — intervention group
Group type: EXPERIMENTAL
Intervention: Aneroid sphygmomanometer (AnS)
Number of subjects: 300
Study 31764009 — intervention group
Group type: COMPARATOR
Intervention: Mercury sphygmomanometer (HgS)
Number of subjects: 300
Study 31848158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 (IG1): personal training with SMS recommendations
Number of subjects: 137
Study 31848158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2 (IG2): e-learning training without SMS
Number of subjects: 137
Study 31848158 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG): regular information letters, online training after 1 year
Number of subjects: 137
Study 27522310 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrebreather mask with flush rate oxygen (NRB-Flush)
Number of subjects: 26
Study 27522310 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve-mask device with oxygen at 15 L/min (BVM-15)
Number of subjects: 26
Study 27522310 — intervention group
Group type: COMPARATOR
Intervention: Nonrebreather mask with oxygen at 15 L/min (NRB-15)
Number of subjects: 26
Study 27522310 — intervention group
Group type: COMPARATOR
Intervention: Simple mask with flush rate oxygen
Number of subjects: 26
Study 25365396 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-item teacher ratings of student readiness
Number of subjects: 350
Study 23609526 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 40
Study 23609526 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 40
Study 23609526 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study 21560012 — intervention group
Group type: EXPERIMENTAL
Intervention: Sling procedure and self‐catheterization in SISTEr
Number of subjects: 1252
Study 21560012 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline recurrent UTI (rUTI; ≥3 in 12 months)
Number of subjects: 1252
Study 21560012 — intervention group
Group type: EXPERIMENTAL
Intervention: PVR > 100 cc at 12 months
Number of subjects: 1252
Study 21560012 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful surgery (negative cough stress test) at 1 year in women with pre‐operative rUTI
Number of subjects: 1252
Study 21560012 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline rUTI
Number of subjects: 1252
Study 18691360 — intervention group
Group type: EXPERIMENTAL
Intervention: TIB restriction (n = 22)
Number of subjects: 42
Study 18691360 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 18)
Number of subjects: 42
Study 16437344 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbactam/ampicillin
Number of subjects: 419
Study 16437344 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 419
Study 16437344 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 419
Study 12766654 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.1% with 5 microg/ml fentanyl
Number of subjects: 555
Study 12766654 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.1% with 5 microg/ml fentanyl
Number of subjects: 555
Study 12766654 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 555
Study 12766654 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 555
Study 11463605 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 15
Study 11463605 — intervention group
Group type: EXPERIMENTAL
Intervention: UTP 20 mg
Number of subjects: 15
Study 11463605 — intervention group
Group type: EXPERIMENTAL
Intervention: UTP 100 mg
Number of subjects: 15
Study 9006398 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 179
Study 9006398 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 179
Study 9006398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 7962342 — intervention group
Group type: EXPERIMENTAL
Intervention: LPL exon 2 variant
Number of subjects: 39
Study 7962342 — intervention group
Group type: COMPARATOR
Intervention: Coding region mutations of the LPL gene
Number of subjects: 39
Study 3118327 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-galactosidase pretreatment of milk
Number of subjects: 0
Study 3118327 — intervention group
Group type: COMPARATOR
Intervention: Lactose solution (35 g)
Number of subjects: 0
Study 3118327 — intervention group
Group type: COMPARATOR
Intervention: Glucose + galactose solution (17.5 + 17.5 g)
Number of subjects: 0
Study 3118327 — intervention group
Group type: COMPARATOR
Intervention: Native skimmed milk
Number of subjects: 0
Study 3118327 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk pretreated with beta-galactosidase
Number of subjects: 0
Study 31205105 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 35 mg orally twice a day for 3 months
Number of subjects: 58
Study 31205105 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments for angina
Number of subjects: 58
Study 27783092 — intervention group
Group type: EXPERIMENTAL
Intervention: Dense cataract group (visual acuity worse than 20/200)
Number of subjects: 0
Study 27783092 — intervention group
Group type: COMPARATOR
Intervention: Control group (visual acuity better than 20/200)
Number of subjects: 0
Study 26241948 — intervention group
Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine with buffer
Number of subjects: 32